Q4 EPS $0.45 vs $0.02 Sales up 83 pct Generic sales rise 95 pct Shares up as much as 31 pct July 14 (Reuters) - Hi-Tech Pharmacal Inc posted higher quarterly profit, helped by generic sales that ...

AUSTIN, Texas (Legal Newsline) – Texas Attorney General Greg Abbott announced a $25 million settlement on Tuesday with a New York-based pharmaceutical manufacturer to resolve allegations the company ...

Should Hi-Tech Pharmacal Co. (NASDAQ:HITK) investors track the following data? To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund ...

NEW YORK (AP) — Hi-Tech Pharmacal said Thursday that it will pay $25 million to resolve allegations that it overcharged the Texas Medicaid program. Your Business section has included another gem: ...

Q4 EPS $1.08 vs est $0.71 Q4 sales $57.2 mln vs est $49.3 mln Generic pharma products sales rose 59 pct Shares up 6 pct in pre-mkt trade (Follows alerts) July 7 (Reuters) - Hi-Tech Pharmacal Co Inc ...

Mario Gabelli's fund GAMCO Investors and its affiliates, have revealed in several filings with the SEC, some of the latest moves related to the holdings in its equity portfolio. As usual, Mario ...

Niche pharmaceutical company Akorn, Inc. (AKRX) said Tuesday morning that it has agreed to pay $640 million in cash, or $43.50 per share, to acquire Hi-Tech Pharmacal Co., Inc. (HITK) . The ...

SAN FRANCISCO (MarketWatch) -- Hi-Tech Pharmacal said Thursday that the Food and Drug Administration cleared its abbreviated new drug application for acyclovir oral suspension 200 mg/5mL, the generic ...